Hormone replacement therapy market – growth, trends, and forecasts (2022 – 2027)

Hormone replacement therapy (HRT) has gained increasing importance in light of the rise in menopausal disorders worldwide, and increasing awareness. This modern treatment methodology replenishes dwindling hormone levels and has had tremendous results, helping to reduce hot flashes, among other menopausal symptoms. 

So what does the future hold for the hormone replacement therapy market? Let’s find out.

Market Growth & Forecasts for HRT

• By 2027, HRT will reel in revenue upwards of $23.92 billion, a long way up from its $17.38 billion valuation in 2020 (Market data forecast)
• The compound annual growth rate (CAGR) is projected to steady at 7.21% between 2022-2027 (Investopedia)
• Hormonal imbalance affects 80% of women, thereby turbocharging the need for HRT by 2028 (Chapel Hill)
• North America ranks as the largest HRT market in the world, while Asia Pacific is the fastest-growing (Globe Newswire)

Trends in HRT: 

• At 47.6%, combination and estrogenic replacement therapy takes up the hugest market share of HRT as a whole
• 92% of HRT therapists would recommend low-dose hormone replacement therapy for family members (PubMed)
• 44% of postmenopausal women have experience with HRT treatment (CDC)
• At 40%, pills rank as the most common hormone preparation type (CDC)
• Skin patches are the least popular hormone preparation type at 4% (CDC)

Benefits of Hormone Replacement therapy:

• 98% of physicians across 6 countries say quality of life improves with HRT (JWH)
• 86% of US doctors find HRT to be the best treatment option for atrophic vaginitis (NCBI)
• 9 in 10 physicians agree HRT benefits far outweigh the risks in ideal candidates (NCBI)
• HRT reduces heart disease risk by 50%, according to 50-year-old observational studies (CMAJ)